Haematology Procedures & Diagnostics
Overview of Haematology
▲Haematology is the medical specialty focused on disorders of the blood, bone marrow, and lymphatic system, including anaemia, clotting disorders, and blood cancers such as leukaemia and lymphoma[cite: 2]. Haematologists rely on laboratory testing, bone marrow evaluation, and imaging to diagnose these conditions, and manage treatment ranging from medication to complex procedures such as stem cell transplantation.
Coagulation Studies
▼Common blood tests used to evaluate how well the blood clots, helping diagnose bleeding disorders and monitor patients on blood-thinning medication.
Iron Infusion
▼A frequently used intravenous treatment to correct iron-deficiency anaemia when oral iron supplements are ineffective or insufficient, allowing more rapid replenishment of the body's iron stores.
Blood Transfusion
▼The administration of donated blood or specific blood components to treat severe anaemia, bleeding, or clotting deficiencies, carefully matched and monitored to reduce the risk of reactions.
Bone Marrow Aspiration and Biopsy
▼A key diagnostic procedure in which a sample of marrow and bone tissue is collected, usually from the hip bone, to help diagnose leukaemia, lymphoma, or unexplained blood cell abnormalities.
Apheresis and Plasmapheresis
▼Specialised procedures that separate and remove specific components of the blood - such as white cells, platelets, or plasma - used both to collect components for treatment and therapeutically in certain autoimmune or haematological conditions.
Stem Cell (Bone Marrow) Transplant
▼A complex, specialised treatment for certain blood cancers and severe bone marrow disorders, in which healthy stem cells from the patient or a donor are infused to rebuild the bone marrow's ability to produce healthy blood cells.
CAR T-Cell Therapy
▼A rare and cutting-edge treatment in which a patient's own immune cells are genetically modified in a laboratory to recognise and attack cancer cells, then infused back into the body[cite: 2]. It is currently used for certain advanced blood cancers that have not responded to standard treatment.